Activation of Hif by Small Molecule Inhibitors of Phd2 Accelerates Wound Healing In Vivo

Michael Hu,Wan Xing Hong,Min Xie,Shibing Tang,Robert Rennert,Graham Walmsley,Zeshaan Maan,Andrew Zimmermann,Geoffrey Gurtner,Amato Giaccia,Peter Lorenz,Sheng Ding,Michael Longaker
2015-01-01
Wound Repair and Regeneration
Abstract:PURPOSE: Impaired wound healing, particularly in diabetic and vasculopathic patients, represents a significant clinical challenge. Prior studies have revealed that an important prognostic determinant of wound repair is the presence of hypoxia. Hypoxia-inducible factor (HIF), master regulator of cellular response to hypoxia, is critical for enhancing the appropriate inflammatory and angiogenic responses that promote wound healing. Herein, we examine the effect of small molecule activators of the HIF pathway on wound healing.METHODS: We generated 25 small molecule analogue inhibitors of PHD2, designated GPHD-1 through GPHD-25. A high throughput HRE-luciferase assay was performed on NIH 3T3 fibroblasts on 96-well plates to identify GPHD compounds that would achieve the greatest increase in the HIF pathway. The best three compounds were tested in vivo using a murine model of wound healing …
What problem does this paper attempt to address?